Sign inGet started

Sarissa Capital Offshore Master Fund LP

Insider CIK 1577530 · APRI 10% owner · RGLS 10% owner · ITRM 10% owner · VVUS

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ITRM Iterum Therapeutics plc S Sale2021-02-122021-02-1210,619,949$2.27 $24.11M0SEC↗
ITRM Iterum Therapeutics plc C Conversion deriv2021-02-112021-02-1215,000,000— $00SEC↗
ITRM Iterum Therapeutics plc S Sale2021-02-112021-02-1210,000,000$2.59 $25.90M10,619,949SEC↗
ITRM Iterum Therapeutics plc C Conversion2021-02-112021-02-1220,619,949— $020,616,949SEC↗
RGLS Regulus Therapeutics Inc. J Other deriv2020-04-012020-05-085,311— $0262,704SEC↗
RGLS Regulus Therapeutics Inc. J Other deriv2020-04-012020-05-0853,113— $02,627,037SEC↗
RGLS Regulus Therapeutics Inc. J Other deriv2020-04-012020-05-0823,243— $01,149,649SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-12-242020-01-03423,162— $0423,162SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-12-242020-01-034,231,620— $06,083,471SEC↗
APRI APRICUS BIOSCIENCES, INC. J Other deriv2018-03-212018-03-23653,409— $00SEC↗
APRI APRICUS BIOSCIENCES, INC. J Other deriv2018-03-212018-03-23653,409— $0653,409SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy deriv2017-08-312017-09-012,835— $0672,453SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy2017-08-312017-09-016,104$1.63 $9.9K1,447,906SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy deriv2016-03-032016-03-073,323,864— $06,724,525SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy2016-03-032016-03-076,647,728$0.88 $5.85M14,479,053SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy deriv2016-01-122016-01-14653,409— $03,400,661SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy2016-01-122016-01-141,306,819$0.88 $1.15M7,831,324SEC↗